Revenue from Contracts with Customers

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

Note 4 – Revenue from Contracts with Customers

Disaggregated Revenue

The Company provided listing sponsorship and consulting services to growth-stage private companies, diagnostic test products and laboratory services to hospitals, clinical laboratories and other healthcare providing customers, and entered into collaboration agreements with government agencies, non-governmental organizations, and healthcare providers. The revenues by type of service consist of the following:

	Years Ended December 31,
	2024		2023
Product sales	$	169,373	$	2,400,053
Laboratory services		26,776		153,719
Listing sponsorship services		5,000,000		-
Collaboration revenue		-		864,548
Total revenue	$	5,196,149	$	3,418,320

Revenues by geography are as follows:

	Years Ended December 31,
	2024		2023
Domestic	$	196,149	$	678,093
International		5,000,000		2,740,227
Total revenue	$	5,196,149	$	3,418,320

Deferred revenue

Changes in deferred revenue for the period were as follows:

Balance at December 31, 2022	$	142,061
Contracts with customers		74,109
Recognized in the current period		(144,196	)
Currency translation adjustment		(46,048	)
Balance at December 31, 2023		25,926
Recognized in the current period		(21,096	)
Refunded to customers in the current period		(4,830	)
Balance at December 31, 2024	$	-